Related Experiment Video
Updated: May 18, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[The evaluation of an instrument for pediatric oncology patient classification]
Sandra de Andrade1, Sérgio Vicente Serrano, Maria Salete de A Nascimento
1Hospital de Câncer de Barretos, Barretos, SP, Brasil. pediatriaint@hcancerbarretos.com.br
Insights
This study evaluated a patient classification instrument for pediatric cancer patients, finding it reliable and reproducible. Minor adjustments are recommended to better suit the specific needs of pediatric oncology patients.
Area of Science:
- Pediatric Oncology
- Healthcare Quality Improvement
- Clinical Classification Systems
Background:
- Accurate patient classification is crucial for effective care delivery in pediatric oncology.
- Existing instruments may require validation and adaptation for specific patient populations.
- Ensuring reproducibility and adequacy of classification tools enhances healthcare quality.
Purpose of the Study:
- To assess the interrater reproducibility of a patient classification instrument in pediatric cancer patients.
- To verify the adequacy of the instrument for classifying pediatric oncology patients.
- To propose modifications for improved suitability in pediatric oncology.
Main Methods:
- A total of 34 pediatric inpatients at a Cancer Hospital were evaluated.
- Classification was performed by interdisciplinary teams including physicians, nurses, and nursing technicians.
- The Kappa coefficient was employed to measure interrater agreement.
Main Results:
- The Kappa coefficient indicated moderate to high agreement for objective classification items.
- Low agreement was observed for subjective classification items.
- The instrument demonstrated reliability and reproducibility.
Conclusions:
- The patient classification instrument is reliable and reproducible for pediatric cancer patients.
- Enhancements to specific items are suggested for better alignment with pediatric oncology patient realities.
- Adaptation of the instrument can improve its utility in specialized pediatric oncology settings.
Abstract:
The objectives of this study were to assess the interrater reproducibility of the instrument to classify pediatric patients with cancer; verify the adequacy of the patient classification instrument for pediatric patients with cancer; and make a proposal for changing the instrument, thus allowing for the necessary adjustments for pediatric oncology patients. A total of 34 pediatric inpatients of a Cancer Hospital were evaluated by the teams of physicians, nurses and nursing technicians. The Kappa coefficient was used to rate the agreement between the scores, which revealed a moderate to high value in the objective classifications, and a low value in the subjective. In conclusion, the instrument is reliable and reproducible, however, it is suggested that to classify pediatric oncology patients, some items should be complemented in order to reach an outcome that is more compatible with the reality of this specific population.
